Invasive properties of multidrug resistant human melanoma cells.
Melanoma cells exhibit a high level of intrinsic or acquired resistance to the cytotoxic agents often associated with the over-expression of drug transporters such as P-glycoprotein (P-gp). In this in vitro study, we investigated the possible relationship between P-gp and CD44, the cell adhesion molecule involved in metastasis and tumor progression of melanoma cells. CD44 expression appeared to be similar in the parental sensitive M14 WT cells and in their resistant counterparts M14 ADR cells. Double-labeling of cryosectioned cells showed that P-gp and CD44 were transported from the synthesis loci to the cell periphery by different vesicles and began to coalesce in proximity of the plasma membrane; thus, P-gp and CD44 seemed to reach together the cell surface. Moreover, P-gp and CD44 appeared to be associated with ERM proteins. The invasive activities of both M14 WT and M14 ADR cells were analyzed by the "transwell chamber invasion" assay. M14 WT cells revealed low capacity to traverse the filters, both in the absence (motility) and in the presence (invasion) of a Matrigel coating. In comparison, M14 ADR cells displayed significantly higher motility and invasion. SEM observations showed that sensitive cells employed lamellar cytoplasmic extrusions to pass through the filter pores whereas resistant cells elongated along the hole through globular processes. In conclusion, the results herein reported suggest that drug resistance in melanoma cells appears associated with a more aggressive behaviour. P-gp and CD44 might cooperate to confer this more invasive phenotype.
Molinari
A
A
Department of Technology and Health, Istituto Superiore di Sanità, Rome, Italy.
Stringaro
A
A
Gentile
M
M
Colone
M
M
Toccacieli
L
L
Arancia
G
G
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism*; D002352:Carrier Proteins / Q000378:metabolism; D015815:Cell Adhesion Molecules / Q000378:metabolism; D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000378:metabolism / Q000648:ultrastructure; D003094:Collagen / Q000378:metabolism; D004338:Drug Combinations; D018432:Drug Resistance, Multiple / Q000502:physiology*; D019008:Drug Resistance, Neoplasm / Q000502:physiology*; D006801:Humans; D018960:Hyaluronan Receptors / Q000378:metabolism*; D007797:Laminin / Q000378:metabolism; D046911:Macromolecular Substances / Q000378:metabolism; D008545:Melanoma / Q000188:drug therapy / Q000503:physiopathology*; D008855:Microscopy, Electron, Scanning; D046529:Microscopy, Electron, Transmission; D009361:Neoplasm Invasiveness / Q000503:physiopathology*; D010641:Phenotype; D021381:Protein Transport / Q000502:physiology; D011509:Proteoglycans / Q000378:metabolism; D011554:Pseudopodia / Q000648:ultrastructure
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D002352:Carrier Proteins; D015815:Cell Adhesion Molecules; D004338:Drug Combinations; D018960:Hyaluronan Receptors; D007797:Laminin; D046911:Macromolecular Substances; D011509:Proteoglycans; C059485:matrigel; D003094:Collagen